137 related articles for article (PubMed ID: 23467757)
1. Two-phase whole-body skeletal scintigraphy in children--revisiting the usefulness of the early blood pool phase.
Kwatra N; Shalaby-Rana E; Majd M
Pediatr Radiol; 2013 Oct; 43(10):1376-84. PubMed ID: 23467757
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide three-phase whole-body bone imaging.
Yang DC; Ratani RS; Mittal PK; Chua RS; Pate SM
Clin Nucl Med; 2002 Jun; 27(6):419-26. PubMed ID: 12045434
[TBL] [Abstract][Full Text] [Related]
3. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bone viability.
Roca I; Barber I; Fontecha CG; Soldado F
Pediatr Radiol; 2013 Apr; 43(4):393-405. PubMed ID: 23525766
[TBL] [Abstract][Full Text] [Related]
5. An audit of paediatric technetium-99m methylene diphosphonate bone scans.
Fishwick NG; Krarup KC; Belton IP; Finlay DB
Br J Radiol; 1994 Jun; 67(798):552-5. PubMed ID: 8032808
[TBL] [Abstract][Full Text] [Related]
6. Ischemic Muscle Necrosis of Lower Extremities in Peripheral Arterial Disease: The Impact of 99mTc-MDP Scintigraphy on Patient Management.
Jocius D; Vajauskas D; Skrebunas A; Gutauskas M; Tamosiunas AE
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31795274
[No Abstract] [Full Text] [Related]
7. Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents.
Morbach H; Schneider P; Schwarz T; Hofmann C; Raab P; Neubauer H; Düren C; Beer M; Girschick HJ
Clin Exp Rheumatol; 2012; 30(4):578-82. PubMed ID: 22765947
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet's disease.
Sahin M; Yildiz M; Tunc SE; Cerci S; Suslu H; Cure E; Kutlucan A
Ann Nucl Med; 2006 Dec; 20(10):649-53. PubMed ID: 17385302
[TBL] [Abstract][Full Text] [Related]
9. Incidental diagnosis of Peyronie disease on bone scintigraphy.
Ho YY; Pua U; Teo LL
Clin Nucl Med; 2006 Sep; 31(9):584-6. PubMed ID: 16921294
[No Abstract] [Full Text] [Related]
10. The diagnostic value of (99m)Tc-IgG scintigraphy in the diabetic foot and comparison with (99m)Tc-MDP scintigraphy.
Asli IN; Javadi H; Seddigh H; Mogharrabi M; Hooman A; Ansari M; Jalallat S; Assadi M
J Nucl Med Technol; 2011 Sep; 39(3):226-30. PubMed ID: 21795373
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy.
Tsubaki F; Kurata S; Nagata S; Fujimoto K; Abe T
Jpn J Radiol; 2016 Dec; 34(12):771-778. PubMed ID: 27688157
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid and bone scintigraphy in hyperparathyroidism.
Shi H; Chen J; Chen S
Clin Nucl Med; 2005 Nov; 30(11):769-70. PubMed ID: 16237313
[No Abstract] [Full Text] [Related]
13. Dosimetric considerations of
Brown JL; Sexton-Stallone B; Li Y; Frey EC; Treves ST; Fahey FH; Plyku D; Cao X; Choi C; Kim CH; Sgouros G; Aris JP; Bolch WE
Phys Med Biol; 2020 Dec; 65(23):235025. PubMed ID: 33263312
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of 99mTc-MDP scintigraphy for normal roentgen variants of bone].
Yamagishi Y; Komata K; Yamamoto H; Takahashi M; Hikita F; Sato M; Watanabe H
Kaku Igaku; 1993 May; 30(5):549-56. PubMed ID: 8336414
[TBL] [Abstract][Full Text] [Related]
15. Abnormal intense skeletal radiotracer uptake on myocardial perfusion imaging with Tc-99m sestamibi.
Gowda A; Peddinghaus L; Shandilya V; Gavriluke A; Jain D
J Nucl Cardiol; 2006; 13(3):427-31. PubMed ID: 16750787
[No Abstract] [Full Text] [Related]
16. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
Tan KF; Chang CH
Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
[No Abstract] [Full Text] [Related]
17. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
18. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
19. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
20. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
